H ypertension is an important modifiable risk factor for cardiovascular disease (CVD) . 1 The populationattributable fraction of hypertension for CVD is approximately 60% in Asia. 2, 3 In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) released an updated guideline with a new criteria for hypertension, defining stage 1 hypertension as systolic blood pressure as 130 mm Hg through 139 mm Hg or diastolic blood pressure as 80 mm Hg through 89 mm Hg. 4 This lower threshold for hypertension was based on multiple meta-analyses that showed higher CVD risk in the stage 1 hypertension blood pressure range. [5] [6] [7] [8] [9] [10] [11] However, most of the study populations from these studies were composed of middle-aged and elderly adults, leaving a relative lack of evidence for young adults aged 20 through 39 years. Although previous cohort studies have investigated the association of blood pressure with CVD among young adults, such studies were limited to men and lacked consideration of certain confounders such as health behaviors or characteristics. [12] [13] [14] Moreover, while the prevalence of hypertension among young adults has increased, hypertension awareness and management levels have nevertheless been low. For example, hypertension prevalence increased from 7.5% to 10.3% during years 2007 to 2016, whereas awareness and treatment levels for hypertension remained less than 20% among young adults aged 30 through 39 years in South Korea. 15 Therefore, the lack of sufficient evidence on whether hypertension, particularly according to the stricter 2017 ACC/AHA criteria, is associated with higher CVD risk among young adults and the increasing prevalence of hypertension in this age group indicate that further studies are needed to investigate the association of blood pressure with CVD among young adults. This nationwide population-based study aimed to investigate the association of blood pressure categories according to the 2017 ACC/AHA guidelines with the risk of CVD among 2.4 million young adults using the Korean National Health Insurance Service (NHIS) database.
Methods

Study Population
The Seoul National University Hospital Institutional Review Board approved this study (IRB number: 1703-039-836 ) and the requirement for informed consent was waived because the NHIS database was constructed after anonymization according to strict confidentiality guidelines.
The NHIS provides mandatory health care for all Korean citizens, with an enrollment rate of 97%. The NHIS collects data from all hospital use including admission and outpatient visit records, drug prescriptions, and national health examination data. Adults aged 20 through 39 years, who are employeeinsured or self-employed are required to undergo health examinations biannually, as provided by the NHIS. 16 The health examination includes a self-reported questionnaire on health behaviors, measurements of height, weight, and blood pressure, and laboratory tests for urine and blood. The NHIS provides information from the claims data for research purposes, which include all of the above-mentioned information along with death records of cause of death and death date merged from the Statistics Korea database. The NHIS database has previously been used for epidemiological studies, and its validity is described elsewhere.
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Key Variables
Blood pressure was measured after participants rested for at least 2 minutes in sitting position by digital or automatic monitors during the health examination. For the main analysis, blood pressure measured nearest to the index date of January 1, 2006, was used. All participants were categorized by blood pressure measures: normal (systolic, <120 mm Hg; diastolic, <80 mm Hg), elevated (systolic, 120-129 mm Hg; diastolic, <80 mm Hg), stage 1 hypertension (systolic 130-139 mm Hg; diastolic, 80-89 mm Hg), and stage 2 hypertension (systolic, ≥140 mm Hg; diastolic, ≥90 mm Hg). Furthermore, the mean blood pressure levels from the first (2002) (2003) and second (2004) (2005) health examination periods were also calculated. For the mean values, the blood pressure measurement closest to January 1, 2002 , was used for the first period and measurement closest to January 1, 2006 , was used for the second period. The primary outcome was CVD, and secondary outcomes included coronary heart disease (CHD) and stroke. A CVD event was defined as 2 or more days of hospitalization or death due to the International Classification of Diseases, Tenth Revision (ICD-10) codes pertaining to CVD. 17, 18 Upon admission, the NHIS requires physicians to designate ICD-10 codes for which the patient was hospitalized. Furthermore, causes of death were also determined by ICD-10 codes determined by the attending physician. Cardiovascular disease (ICD-10 codes, I20-I25, I60-I69) was divided into CHD (ICD-10 codes, I20-I25) and stroke (ICD-10 codes, I60-I69) in accordance with the AHA guidelines.
pressure after adjustments for all covariates. The considered covariates included age (continuous, years), household income (categorical, first, second, third, or fourth quartiles), smoking (categorical, never, past, and current smokers), physical activity (categorical, 0, 1-2, 3-4, 5-6, and 7 times per week), alcohol consumption (categorical, 0, <1, 1-2, 3-4, and ≥5 times per week), body mass index (BMI, continuous), fasting serum glucose (continuous, mg/dL), total cholesterol (continuous, mg/dL), and Charlson comorbidity index (continuous). Household income was determined according to the insurance premium, and body mass index, by dividing the weight in kilograms by height in meters squared. The proportional hazards assumption was graphically tested and verified using the Schoenfeld residual method. The assumption for proportionality was not violated. Participants with missing data on blood pressure or covariates were excluded from the final study population prior to analysis. Starting from the index date of January 1, 2006, all participant prescription records were checked for antihypertensive prescriptions during outpatient department visits or hospitalizations until 2010. Participants with prescriptions for antihypertensive medications within the first 5 years of follow-up were categorized into those with antihypertensive medications. From this, a stratified analysis on the association of blood pressure with CVD according to subgroups of those prescribed antihypertensive medications during the first 5 years of follow-up was conducted, after which the subgroups were tested for interaction. Furthermore, CVD risk was determined using the mean blood pressure values during the first and second health examination measurements. The risk of blood pressure categories on CVD was determined with additive adjustments of covariates with 4 models. Stratified analyses of CVD for subgroups of age, BMI, fasting serum glucose levels, total cholesterol levels, and Charlson comorbidity index were conducted and compared using P values for interaction. Restricted cubic splines were constructed for adjusted HRs and 95% CIs according to blood pressure levels. 20 In accordance with a previous study, 4 knots were placed at the fifth, 35th, 65th, and 95th percentiles of systolic or diastolic blood pressure.
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We defined 2-sided P values of <.05 as statistically significant. All data collection and statistical analyses were performed using SAS version 9.4 (SAS Institute Inc) and STATA version 14 (Stata Corp).
Results
During the 2002-2005 period, 2 692 643 individuals aged 20 through 39 years underwent health examinations. Of those, 1661 participants (0.1%) with missing values for blood pressure and 73 258 (2.7%) with missing covariates were excluded. The 89 participants (<0.5%) who died and the 8517 (0.3%) who were diagnosed with CVD were also excluded; 121 017 participants (4.5%) who were prescribed antihypertensive medications were excluded, resulting in a final study population of 2 488 101 participants ( Figure 1 ). eTable 1 in the Supplement shows the descriptive characteristics of the final study population and those excluded for being prescribed antihypertensives. 
Primary End Points
Cardiovascular disease outcomes, the primary end point, according to 2017 ACC/AHA guideline categories are shown in There was a significant difference in the association of 2017 ACC/AHA categories on CVD according to subgroups of those with and without antihypertensive medication prescribed within the first 5 years of follow-up (P for interaction, <.001 for both men and women). Similar relationships were observed when restricted cubic splines were used to treat systolic and diastolic blood pressure as continuous variables for men and women (Figure 2) . The association of systolic and diastolic blood pressure with CVD is shown in Figure 2 . Systolic blood pressure higher than 120 mm Hg was associated with elevated CVD risk in a dose-responsive manner for both men and women. Similarly, diastolic blood pressure higher than 80 mm Hg was associated with increased risk of CVD for both men and women. The risk-increasing association of high blood pressure with CVD risk was preserved among unadjusted (eFigure 1 in the Supplement) and age-adjusted (eFigure 2 in the Supplement) models. The association of blood pressure categories with CVD risk according to additive adjustments of covariates is shown in eTable 3 in the Supplement. Compared with participants with normal blood pressure, those with stage 1 hypertension had an additional 5.1 and 3.9 CVD events per 1000 men and women, respectively (eTable 4 in the Supplement). Participants with stage 1 hypertension for all subgroups of age, BMI, fasting serum glucose, total cholesterol, and Charlson comorbidity index had higher risk of CVD than did those with normal blood pressure (eTable 5 in Supplement). Solid lines indicate hazard ratios and shaded areas indicate 95% CIs using restricted cubic spline regression. Without antihypertensive medication indicates that patients had not been prescribed antihypertensive medication within the first 5 years of follow-up; with antihypertensive medication indicates that they were prescribed antihypertensive medication within the first 5 years of follow-up.
Restricted cubic splines were constructed with 4 knots placed at the fifth, 35th, 65th, and 95th percentiles. Hazard ratios were calculated by Cox proportional hazards regression analysis after adjustments for age, household income, physical activity, smoking, alcohol consumption, body mass index, fasting serum glucose and total cholesterol levels, and Charlson comorbidity index. Results from previous studies that determined the association of blood pressure on CVD among young adults are in line with those from this study. In a study involving 9887 young men aged 15 through 29 years, it has been shown that every 10 mm Hg increase in systolic blood pressure was associated with an adjusted HR of 1.14 (95% CI, 1.05-1.23) for CVD mortality.
14 Similarly, another study consisting of 10 874 men aged 18 through 39 years demonstrated that increases in 15 mm Hg of systolic blood pressure or 10 mm Hg of diastolic blood pressure were associated with an adjusted HR of 1.26 (95% CI, 1.11-1.44) or 1.17 (95% CI, 1.01-1.35) for CHD mortality, respectively. 13 A nationwide cohort study involving 1 207 141 adolescent men showed that blood pressure higher than 120/80 mm Hg was associated increased risk of CVD mortality.
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However, previous studies were limited to men and lacked adjustments for certain potentially important confounders such as BMI, fasting serum glucose concentrations, or total cholesterol levels. This study not only included women but also demonstrated that the higher CVD risk associated with higher blood pressure was also true after adjustments for a wide range of covariates including BMI, fasting serum glucose, and total cholesterol, thus enhancing the generalizability of the results. Participants with antihypertensive medication prescribed before the index date were excluded as the duration of hypertension since initial diagnosis or dose and types of antihypertensive medications prescribed may have effects on both blood pressure levels and CVD risk. 31 Nevertheless, in an attempt to determine whether pharmacological management may be associated with a lower risk of CVD particularly among patients with stage 1 hypertension, a stratified analysis according to subgroups of antihypertensive medication prescription within the first 5 years of follow-up was conducted. Although patients with stage 1 hypertension not taking antihypertensive medications had higher risk of CVD, those who were prescribed antihypertensives did not have increased CVD risk compared with their respective normal blood pressure groups. Although this appears to suggest that early antihypertensive management of stage 1 hypertension even among young adults may be associated with reduced CVD risk, this result is subject to a number of potentially confounding factors such as differences in access to care and number of medical contacts. Therefore, future prospective studies are needed to validate these findings. Although the absolute risks for CVD were lower in this age group than that of previous studies involving middle-aged and elderly adults, 32 there were nevertheless increases in absolute risk for stage 1 hypertension compared with participants with normal blood pressure. Compared with those with normal blood pressure, men with stage 1 hypertension had additional 5.1 events and women, an additional 3.9 events per 1000. Therefore, despite the relatively low absolute risk, the difference in absloute risk and the fact that sustained hypertension during longer durations is associated with higher risk of CVD indicate that early blood pressure management among young adults may lead to significant public health benefits by reducing CVD risk later in life. This study has a number of strengths. The large study population as well as the inclusion of women add to the reliability of the findings. Furthermore, a number of confounders, including household income, health behaviors, and health characteristics, and comorbidities were taken into account.
Limitations
This study has several limitations. First, blood pressure was measured only once and measurements were not conducted according to rigorous contemporary standards, which could lead to inaccurate blood pressure values. However, blood pressure measurement instruments in all health examination institutions receive quality assessment every 3 years according to the Basic Act on National Health Examination. Furthermore, because mean blood pressure calculated from repeated measurements may be better associated with CVD risk, 33 we also used mean blood pressure measurements from 2 separate blood pressure values over a 2-year span and determined their association with CVD risk, the results of which were consistent with those from the main findings. Nevertheless, future studies that use other methods of blood pressure measurement are needed to validate the findings of this study, particularly since white coat hypertension has been reported to be prevalent among young adults.
34 Second, the operational definition of CVD may be prone to misdiagnosis, as evidenced by the unusually higher rate of CHD compared with stroke among men and the low autopsy rate (1.9% of all deaths
Research Original Investigation Cardiovascular Disease Rates Among Young Korean Adults by 2017 ACC/AHA Hypertension Guideline Definitions according to a report in 2013 35 ) in South Korea. Although the operational definition of CVD used in this study has been adopted from multiple previous studies using the same data source, 17, 18 future studies that use a more accurate definition of CVD are needed to validate these findings. Third, the study population was from a single country, so the results may not necessarily be generalizable to people of other racial or ethnic backgrounds. Fourth, ischemic and hemorrhagic stroke could not be analyzed separately due to lack of data. Future studies that investigate the association of blood pressure on ischemic and hemorrhagic stroke are needed. Fifth, we did not take into account other CVD medications outside of antihypertensives that also lower blood pressure. Sixth, there was also no data available on adherence to reduced salt intake or other dietary recommendations, as well as type of physical activity, which may be important confounders in the association of blood pressure with CVD. Future studies that take into account a more comprehensive range of factors including CVD medications, dietary habits, and physical activity type are needed to validate the findings of this study.
Conclusions
Among Korean young adults, stage 1 and stage 2 hypertension, compared with normal blood pressure, were associated with increased risk of subsequent cardiovascular disease events. Young adults with hypertension, defined by the 2017 ACC/AHA criteria, may be at increased risk of cardiovascular disease. 
